Arnaud M Didierlaurent
Overview
Explore the profile of Arnaud M Didierlaurent including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
2790
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chiacchiari V, Emery O, Olivier L, Schaffner M, Siver N, Cosson P, et al.
Rev Med Suisse
. 2025 Mar;
21(908):468-469.
PMID: 40045839
No abstract available.
2.
Schwab J, Foglierini M, Pescosolido E, Pacheco I, Ruiz Buendia G, Madelon N, et al.
Commun Med (Lond)
. 2024 Nov;
4(1):254.
PMID: 39616213
Background: New onsets of chronic urticaria (CU) have been reported after repeated immunizations, mainly with the Moderna mRNA-1273 vaccine (Spikevax). This study aims to evaluate patients with CU after COVID-19...
3.
Klinkardt U, Schunk M, Ervin J, Schindler C, Sugimoto D, Rankin B, et al.
Hum Vaccin Immunother
. 2024 Oct;
20(1):2410574.
PMID: 39397784
Next-generation COVID-19 vaccines are being developed to expand the breadth of coverage against existing and future variants and to extend the duration of protection. Prime-2-CoV_Beta is an orf virus (ORFV)...
4.
Stylianou V, Bertram K, Vo V, Dunn E, Baharlou H, Terre D, et al.
J Clin Invest
. 2024 Sep;
134(22).
PMID: 39316442
Vaccine adjuvants are thought to work by stimulating innate immunity in the draining lymph node (LN), although this has not been proven in humans. To bridge the data obtained in...
5.
Functional and epigenetic changes in monocytes from adults immunized with an AS01-adjuvanted vaccine
Bechtold V, Smolen K, Burny W, de Angelis S, Delandre S, Essaghir A, et al.
Sci Transl Med
. 2024 Jul;
16(758):eadl3381.
PMID: 39083587
The adjuvant AS01 plays a key role in the immunogenicity of several approved human vaccines with demonstrated high efficacy. Its adjuvant effect relies on activation of the innate immune system....
6.
Gualtieri R, Yerly S, Garcia-Tarodo S, Parvex P, Rock N, Posfay-Barbe K, et al.
Pediatr Allergy Immunol
. 2024 May;
35(5):e14161.
PMID: 38796784
Background: Treatment with anti-CD20 antibodies (rituximab) is used in both adults and children to treat various autoimmune and oncological diseases. Rituximab depletes B CD20+ cells and, thereby, antibody response to...
7.
Hentzien M, Bonnet F, Bernasconi E, Biver E, Braun D, Munting A, et al.
BMC Infect Dis
. 2024 Mar;
24(1):329.
PMID: 38504173
Background: The burden of herpes zoster (shingles) virus and associated complications, such as post-herpetic neuralgia, is higher in older adults and has a significant impact on quality of life. The...
8.
Bekliz M, Thiriard A, Stringhini S, Marchant A, Didierlaurent A, Meyer B, et al.
Pediatr Infect Dis J
. 2024 Feb;
43(5):e189-e191.
PMID: 38306593
No abstract available.
9.
Martinez-Murillo P, Huttner A, Lemeille S, Medaglini D, Ottenhoff T, Harandi A, et al.
Front Immunol
. 2024 Jan;
14:1279003.
PMID: 38235127
Background: During the last decade Ebola virus has caused several outbreaks in Africa. The recombinant vesicular stomatitis virus-vectored Zaire Ebola (rVSVΔG-ZEBOV-GP) vaccine has proved safe and immunogenic but is reactogenic....
10.
Schuind A, Rees H, Schiller J, Mugo N, Dull P, Barnabas R, et al.
Prev Med Rep
. 2023 Aug;
35:102331.
PMID: 37576844
The burden of cervical cancer is disproportionately distributed globally, with the vast majority of cases occurring in low- and middle-income countries. Women with human immunodeficiency virus (HIV) (WWH) are at...